2020
DOI: 10.1192/bjo.2020.97
|View full text |Cite
|
Sign up to set email alerts
|

UK psychiatrists’ experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism

Abstract: Background A high proportion of adults with intellectual disabilities are prescribed off-licence antipsychotics in the absence of a psychiatric illness. The National Health Service in England launched an initiative in 2016, ‘Stopping over-medication of people with a learning disability [intellectual disability], autism or both’ (STOMP), to address this major public health concern. Aims To gain understanding from UK psychiatrists working with adults with intellectual disabilities on the s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
43
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
3
1

Relationship

2
6

Authors

Journals

citations
Cited by 28 publications
(44 citation statements)
references
References 29 publications
(52 reference statements)
1
43
0
Order By: Relevance
“…A multitude of factors influence prescribing of psychotropic medications, which are not easy to unpick at the best of times. Recent studies 24 , 26 and the recent Royal College of Psychiatrists report 27 highlight the complexity of the problem of high usage of psychotropic prescribing in PwID. However, these have not taken into consideration the added impact of the pandemic.…”
Section: Discussionmentioning
confidence: 99%
“…A multitude of factors influence prescribing of psychotropic medications, which are not easy to unpick at the best of times. Recent studies 24 , 26 and the recent Royal College of Psychiatrists report 27 highlight the complexity of the problem of high usage of psychotropic prescribing in PwID. However, these have not taken into consideration the added impact of the pandemic.…”
Section: Discussionmentioning
confidence: 99%
“…Antipsychotics are frequently prescribed to patients with intellectual disabilities and challenging behaviours. However, this practice has raised concerns because of the potential side effects of antipsychotics and because of the lack of concrete evidence on the efficacy of antipsychotics in this population (Branford, 1996; Chapman et al , 2006; Clarke, 1997; Deb et al , 2020). This audit examined the antipsychotic prescribing patterns for people with intellectual disabilities and challenging behaviours in the MHS in Qatar.…”
Section: Discussionmentioning
confidence: 99%
“…There have been growing concerns about the use of antipsychotics in patients with intellectual disabilities (Clarke, 1997; Deb et al , 2020). At present, for adults, there is no trial-based evidence on the effectiveness of antipsychotics on challenging behaviour (Bowring et al , 2017).…”
Section: Introductionmentioning
confidence: 99%
“…In ANDREA‐LD, it was apparent that much of the concern from clinicians around the intervention did not relate to the practicalities of clinical management (participants could safely progress through to full withdrawal) but rather to wider care team co‐operation (as also reported by Deb et al, 2020) and some elements of research procedure—specifically consent. Clinicians and carers would have been familiar with the Mental Capacity Act (Shickle, 2006) which makes provisions relating to the care, treatment and decisions made on behalf of people who lack capacity.…”
Section: Discussionmentioning
confidence: 99%